<DOC>
	<DOCNO>NCT00264017</DOCNO>
	<brief_summary>In past ten year , new drug selective affinity alpha-receptor introduce . Alfuzosin ( Uroxatral ) Tamulosin ( Flomax two second generation alpha-blocker . In course clinical proctice , drug use routinely . This retrospective comparison intend priliminary comparison effectiveness side effect .</brief_summary>
	<brief_title>Palladium-103 Seed Implant Single Daily Dosing Uroxatral Vs. Twice Daily Dosing Flomax- A 3 Month Retrospective Efficacy Analysis</brief_title>
	<detailed_description />
	<mesh_term>Alfuzosin</mesh_term>
	<criteria>Males age 4580 year Diagnosis prostate cancer Status post IMRT Palladium103 seed implantation initiate alpha blocker therapy alfuzosin10mg daily tamulosin 0.4mg bid time seed implantation Baseline AUA score &lt; =12 May antiandrogenand/or alpha reductase therapy Patients receive IMRT follow Palladium103 Brachytherapy implantation primary therapy prostate cancer curatives intent History insulindependent diabetes Uncontrolled hypertention History symptomtic hypotension ( include syncope dizziness ) Preexisting obstructive uropathy base history BPH Acute Urinary Retention Preexisting prostatitis either continuous intermittent Concurrent use anticholinergic previous concurrent usage LHRH agonist</criteria>
	<gender>Male</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>November 2005</verification_date>
</DOC>